rana mckay, md, discusses checkmate214 investigating nivolumab ipilimumab in 1st line rcc patients
Published 4 years ago • 80 plays • Length 1:01
Download video MP4
Download video MP3
Similar videos
-
1:49
bradley mcgregor, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
0:52
dr. mckay on fda approval of nivolumab/ipilimumab in frontline rcc
-
2:37
rana mckay md, explains approach to treating 2nd-line rcc patients who have received i-o combination
-
4:10
rana mckay, md, discusses the design and outcomes of the phase 3 randomized keynote 426 study in rcc
-
3:52
rana mckay, md, discusses factors considered when deciding which patients to get an i-o combo in rcc
-
1:21
rana mckay, md, considers the implications of checkmate 214 & keynote-426 presented at gu 2019
-
1:28
rana mckay, md, discusses the unmet needs for clinical trials addressing non-clear cell rcc
-
0:51
rana mckay, md, elaborates on presented data investigating atezolizumab and cabozantinib in mcrpc
-
8:57
a dummies guide to diagnosis of renal tumors using pattern-based approach
-
17:20
mit family translocation renal cell carcinoma
-
36:53
take control of kidney cancer: what you need to know
-
1:23
rana mckay, md, on recent data examining atezolizumab and bevacizumab in nccrcc & sccrcc
-
1:27
dr. hammers on nivolumab/ipilimumab data in rcc
-
1:39
rana mckay, md, deliberates on patient types appropriate to receive a tki in the treatment of rcc
-
1:23
rana mckay, md, explains how to differentiate between tkis available for renal cell cancer patients
-
0:59
checkmate 8hw: hrqol outcomes of nivolumab and ipilimumab in msi-h/dmmr mcrc
-
1:52
toni choueiri, md, describes potential importance of combining ipi/nivo for 1st line rcc patients
-
0:44
rana mckay, md, elaborates on the outcomes of the keynote 426 phase iii study in mrcc
-
1:01
rana mckay, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc
-
0:33
rana mckay, md, offers impressions of the tivo-3 study in highly refractory advanced rcc patients
-
0:58
rana mckay, md, discusses mrcc patients whose cancer returns and were previously treated with i-o
-
0:53
rana mckay, md, shares exciting potential of current late-stage clinical studies in rcc patients
Clip.africa.com - Privacy-policy